Report Description

Global Oral Clinical Nutrition Market is poised to grow at an impressive rate during the forecast period on account of rising incidence  of chronic diseases, and an increasing focus on patient-centric care. In addition, the growing prevalence of malnutrition and related conditions such as sarcopenia and cachexia are also fueling demand for the products.

Increasing demand for products that provide essential nutrients to patients who are unable to consume adequate amounts of food through normal means. This market encompasses a wide range of products, including supplements, enteral feeding formulas, and medical foods, all designed to provide patients with the nutrients they need to support their recovery and maintain their health.

One of the key drivers of the global oral clinical nutrition market is the increasing prevalence of chronic diseases, such as diabetes, cardiovascular disease, and cancer. These conditions can lead to malnutrition, which in turn can exacerbate the patient's health problems and increase the risk of complications. As a result, healthcare providers are increasingly turning to oral clinical nutrition products to help manage these conditions and improve patient outcomes.


Another key factor driving the oral clinical nutrition market is the aging population. As the population ages, the risk of malnutrition and related conditions increases, as does the need for products that can provide essential nutrients to support overall health and wellbeing. This has led to a growing demand for oral clinical nutrition products that are specifically designed for elderly patients, such as high-protein supplements and fortified meal replacements.


The market for oral clinical nutrition products is also being driven by a growing focus on patient-centric care. Healthcare providers are increasingly recognizing the importance of personalized nutrition in improving patient outcomes and are turning to oral clinical nutrition products to provide patients with the nutrients they need to support their recovery and maintain their health. This trend is also being driven by the rise of value-based care models, which prioritize patient outcomes and require healthcare providers to take a more holistic approach to patient care.


Oral clinical nutrition products are constantly evolving, with new products being developed and launched to meet the changing needs of patients and healthcare providers. Nestle Health Science launched Peptamen 100 ICU, a high-protein enteral formula specifically designed for critically ill patients in 2019. The product contains a unique blend of whey and casein proteins, which are rapidly and slowly absorbed respectively, providing sustained protein delivery to support muscle protein synthesis. Peptamen 100 ICU is also rich in antioxidants, which are essential for supporting the immune system and reducing oxidative stress.


Abbott launched Ensure Max Protein in 2020, a high-protein oral nutritional supplement designed to support muscle health and recovery. The product contains 30 grams of protein per serving, along with essential nutrients such as vitamins and minerals. It is available in three flavors and is designed for use as a snack or meal replacement.


Danone launched Nutricia Age Care in 2021, a range of specialized oral clinical nutrition products designed to meet the unique nutritional needs of elderly patients. The range includes products such as Fortimel Energy, a high-protein oral nutritional supplement, and FortiCare, a specialized enteral formula designed to support wound healing and recovery.


Patient compliance, cost, adverse effects, product availability, and nutritional adequacy are the factors that will hamper the growth of global oral clinical nutrition market in the forecast period.


One of the biggest challenges in global oral clinical nutrition market is patient compliance. Patients may find it difficult to adhere to strict dietary regimens or may have difficulty swallowing or digesting certain products. This can lead to inadequate nutrient intake and reduced effectiveness of the intervention. Healthcare providers must work closely with patients to ensure that they understand the importance of oral clinical nutrition and are able to comply with the prescribed treatment plan. Another challenge is the cost. These products can be expensive, and insurance coverage may be limited or nonexistent. This can make it difficult for patients to obtain the necessary products, especially if they require long-term use. Healthcare providers must work with patients and their families to explore options for financial assistance and insurance coverage.

 

Increasing Focus on Patient-Centric Care


The increasing focus on patient-centric care is influencing the growth of the global oral clinical nutrition market in several ways. Patient-centric care is a healthcare approach that focuses on putting the patient at the center of care and tailoring treatment plans to their individual needs and preferences. This approach is becoming more prevalent in healthcare as patients are becoming more informed and empowered in their healthcare decision-making.


The increasing focus on patient-centric care is driving the growth of the global oral clinical nutrition market by increasing the demand for personalized nutrition solutions, emphasizing the importance of quality and safety, and highlighting the need for patient education and support.


Patient-centric care is influencing the growth of the global oral clinical nutrition market by increasing the demand for personalized nutrition solutions. Patients with different medical conditions and nutritional needs require different types of nutritional support. For example, a patient with cancer may require a high-protein, high-calorie diet to maintain their weight and muscle mass during treatment, while a patient with diabetes may require a low-sugar diet to control their blood sugar levels. As patients become more informed about their healthcare and demand more personalized care, there is a growing need for oral clinical nutrition products that can be tailored to their specific nutritional needs.


Patient-centric care is driving the growth of the oral clinical nutrition market by increasing the emphasis on the quality and safety of oral nutrition products. Patients are becoming more aware of the risks associated with poor nutrition, such as malnutrition, dehydration, and gastrointestinal complications. As a result, they are demanding high-quality and safe oral nutrition products that can help them maintain their health and well-being. This demand for safe and effective oral clinical nutrition products is driving innovation in the industry, with companies developing new and improved formulations that meet the needs of patients with different medical conditions.


Patient-centric care is influencing the growth of the global oral clinical nutrition market by increasing the importance of patient education and support. Patients who receive oral clinical nutrition products need to be educated on how to use them correctly and effectively. This includes guidance on how to incorporate oral nutrition products into their daily routine, how to prepare and administer them, and how to monitor their nutritional status. Patients also require ongoing support and monitoring to ensure that they are achieving their nutritional goals and maintaining their health. As a result, there is a growing need for healthcare professionals who can provide this education and support to patients, which is driving the growth of the global oral clinical nutrition market.

 

Increasing Prevalence of Malnutrition and other related diseases


The increasing prevalence of malnutrition and related diseases is one of the key factors driving the growth of the global oral clinical nutrition market. Malnutrition is a condition caused by a lack of essential nutrients in the body, which can lead to a range of health problems, including weakened immune systems, slower wound healing, and impaired growth and development. Malnutrition is particularly prevalent in patients with chronic diseases, such as cancer, HIV/AIDS, and diabetes, as these conditions can affect the body's ability to absorb and utilize nutrients.


As the incidence of chronic diseases continues to rise globally, the demand for oral clinical nutrition products is increasing as well. Oral clinical nutrition products, such as specialized enteral formulas and supplements, are designed to provide the essential nutrients that patients with malnutrition or other related diseases may not be able to obtain through their regular diet.


The increasing prevalence of malnutrition and related diseases, coupled with a growing focus on patient-centric care and the availability of innovative nutrition solutions, is driving the growth of the global oral clinical nutrition market.




Download Free Sample Report


Market Segmentation


Global Oral Clinical Nutrition Market can be segmented by indication, by distribution channel, by region and competitive landscape. Based on indication, the market can be divided into Alzheimer’s, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, and Others. Based on distribution channel, the market is divided into Direct Sales and Indirect Sales. Regionally, the Oral Clinical Nutrition market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

 

Market Players


Abbott Laboratories, Inc., Pfizer, Inc., Bayer AG, Nestle SA, GlaxoSmithKline plc., Baxter International Inc., Otsuka Holdings, Co. Ltd., Baxter International Inc., Victus, Inc., Danone SA(Nutricia), are some of the leading players operating in the Global Oral Clinical Nutrition Market.


Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

By Indication

By Distribution Channel

Regional scope

North America, Europe, Asia Pacific, South America, Middle East & Africa

Key companies profiled

Abbott Laboratories, Inc., Pfizer, Inc., Bayer AG, Nestle SA, GlaxoSmithKline plc., Baxter International Inc., Otsuka Holdings, Co. Ltd., Baxter International Inc., Victus, Inc., Danone SA(Nutricia)

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Global Oral Clinical Nutrition Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  •  Oral Clinical Nutrition Market, By Indication:

o      Alzheimer’s

o      Nutritional Deficiencies

o      Cancer Care

o      Chronic Kidney Disease

o      Dysphagia

o      Others

            ·      Oral Clinical Nutrition Market, By Distribution Channel:

o      Direct Sales

o      Indirect Sales

            ·      Oral Clinical Nutrition Market, By Region:

o      North America

o   United States

o   Canada

o   Mexico

o      Europe

o   France

o   Germany

o   United Kingdom

o   Italy

o   Spain

o      Asia Pacific

o   China

o   India

o   Japan

o   South Korea

o   Australia

o      South America

o   Brazil

o   Argentina

o   Colombia

o      Middle East & Africa

o   South Africa

o   Saudi Arabia

o   UAE

 

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Oral Clinical Nutrition Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Oral Clinical Nutrition Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validations

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Oral Clinical Nutrition Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Indication (Alzheimer’s, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others)

5.2.2.     By Distribution Channel (Direct Sales v/s Indirect Sales)

5.2.3.     By Region

5.2.4.     By Company (2022)

5.3.  Product Map

5.3.1.     By Indication

5.3.2.     By Distribution Channel

5.3.3.     By Region

6.    North America Oral Clinical Nutrition Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Indication

6.2.2.     By Distribution Channel

6.2.3.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Oral Clinical Nutrition Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Indication

6.3.1.2.2.             By Distribution Channel

6.3.2.     Canada Oral Clinical Nutrition Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Indication

6.3.2.2.2.             By Distribution Channel

6.3.3.     Mexico Oral Clinical Nutrition Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Indication

6.3.3.2.2.             By Distribution Channel

7.    Europe Oral Clinical Nutrition Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Indication

7.2.2.     By Distribution Channel

7.2.3.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Oral Clinical Nutrition Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Indication

7.3.1.2.2.             By Distribution Channel

7.3.2.     Germany Oral Clinical Nutrition Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Indication

7.3.2.2.2.             By Distribution Channel

7.3.3.     United Kingdom Oral Clinical Nutrition Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecasty

7.3.3.2.1.             By Indication

7.3.3.2.2.             By Distribution Channel

7.3.4.     Italy Oral Clinical Nutrition Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Indication

7.3.4.2.2.             By Distribution Channel

7.3.5.     Spain Oral Clinical Nutrition Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Indication

7.3.5.2.2.             By Distribution Channel

8.    Asia-Pacific Oral Clinical Nutrition Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Indication

8.2.2.     By Distribution Channel

8.2.3.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Oral Clinical Nutrition Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Indication

8.3.1.2.2.             By Distribution Channel

8.3.2.     India Oral Clinical Nutrition Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Indication

8.3.2.2.2.             By Distribution Channel

8.3.3.     Japan Oral Clinical Nutrition Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Indication

8.3.3.2.2.             By Distribution Channel

8.3.4.     South Korea Oral Clinical Nutrition Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Indication

8.3.4.2.2.             By Distribution Channel

8.3.5.     Australia Oral Clinical Nutrition Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Indication

8.3.5.2.2.             By Distribution Channel

9.    South America Oral Clinical Nutrition Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Indication

9.2.2.     By Distribution Channel

9.2.3.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Oral Clinical Nutrition Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Indication

9.3.1.2.2.             By Distribution Channel

9.3.2.     Argentina Oral Clinical Nutrition Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Indication

9.3.2.2.2.             By Distribution Channel

9.3.3.     Colombia Oral Clinical Nutrition Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Indication

9.3.3.2.2.             By Distribution Channel

10.  Middle East and Africa Oral Clinical Nutrition Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Indication

10.2.2.  By Distribution Channel

10.2.3.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Oral Clinical Nutrition Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Indication

10.3.1.2.2.           By Distribution Channel

10.3.2.  Saudi Arabia Oral Clinical Nutrition Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Indication

10.3.2.2.2.           By Distribution Channel

10.3.3.  UAE Oral Clinical Nutrition Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Indication

10.3.3.2.2.           By Distribution Channel

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Recent Development

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Global Oral Clinical Nutrition Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products